Edition:
United States

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

7.59USD
15 Dec 2017
Change (% chg)

$0.28 (+3.90%)
Prev Close
$7.31
Open
$7.30
Day's High
$7.81
Day's Low
$7.23
Volume
89,503
Avg. Vol
53,829
52-wk High
$10.24
52-wk Low
$2.43

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David Madden

53 2009 Independent Chairman of the Board

Douglas Fambrough

46 2013 President, Chief Executive Officer, Director

John Green

62 2016 Chief Financial Officer, Principal Financial Officer

Bob Brown

50 2012 Senior Vice President, Chief Scientific Officer

Theodore Ashburn

47 2014 Senior Vice President - Product Strategy & Operations